title: Reply to Mieke Van Hemelrijck, Hans Garmo, Jan Adolfsson, and Pär Stattin's Letter to the Editor re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism. Eur Urol 2016;70:56-61.
authors: Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada.
authors: Adi J
authors: AJ
authors: Klil-Drori
authors: Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, Canada. Electronic address: laurent.azoulay@mcgill.ca.
authors: Laurent
authors: L
authors: Azoulay
mesh_terms: D000726:Androgen Antagonists; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D012306:Risk; D054556:Venous Thromboembolism
chemical_list: D000726:Androgen Antagonists